Lantern Pharma Inc (LTRN)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -767.111 | -257.886 | -54.219 | -26.218 | -21.478 | -31.15 |
| Return on Equity (%) | 1708.911 | -655.331 | -57.243 | -27.091 | -22.35 | -32.93 |
| Return on Invested Capital (%) | 1708.911 | -882.909 | -57.755 | -27.902 | -22.806 | -36.899 |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | -0.178 | 0.829 | 3.167 | 6.454 | 5.161 | 3.764 |
| Earnings Per Share | -1.518 | -2.135 | -0.95 | -1.115 | -1.313 | -1.469 |
| Cash Per Share | 0.391 | 1.084 | 3.091 | 4.646 | 3.427 | 2.018 |
| Working Capital Per Share | -0.182 | 0.653 | 3.164 | 6.348 | 5.151 | 3.741 |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | -1.518 | -2.135 | -0.95 | -1.115 | -1.313 | -1.469 |
| EBITDA Per Share | -1.518 | -2.135 | -0.95 | -1.115 | -1.313 | -1.469 |
| Free Cash Flow Per Share | -1.518 | -2.132 | -0.948 | -1.114 | -1.312 | -1.468 |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 1.14M | 1.14M | 6.22M | 11.09M | 10.86M | N/A |
| Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Shares Outstanding | 10.83M | 10.86M | 10.86M | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 47.36M |
| Price to Earnings Ratio | -2.97 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.16 |
| Price to Book Ratio | 1.16 |
| Dividend Yield | - |
| Shares Outstanding | 10.76M |
| Average Volume (1 week) | 35.6k |
| Average Volume (1 Month) | 54.28k |
| 52 Week Change | -6.78% |
| 52 Week High | 11.99 |
| 52 Week Low | 2.38 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
